Department of Gastroenterology, Eastern Health Clinical School, Monash University, Box Hill, Victoria, Australia.
Gastroenterology. 2013 Aug;145(2):320-8.e1-3. doi: 10.1053/j.gastro.2013.04.051. Epub 2013 May 4.
BACKGROUND & AIMS: Patients with non-celiac gluten sensitivity (NCGS) do not have celiac disease but their symptoms improve when they are placed on gluten-free diets. We investigated the specific effects of gluten after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates (fermentable, oligo-, di-, monosaccharides, and polyols [FODMAPs]) in subjects believed to have NCGS.
We performed a double-blind cross-over trial of 37 subjects (aged 24-61 y, 6 men) with NCGS and irritable bowel syndrome (based on Rome III criteria), but not celiac disease. Participants were randomly assigned to groups given a 2-week diet of reduced FODMAPs, and were then placed on high-gluten (16 g gluten/d), low-gluten (2 g gluten/d and 14 g whey protein/d), or control (16 g whey protein/d) diets for 1 week, followed by a washout period of at least 2 weeks. We assessed serum and fecal markers of intestinal inflammation/injury and immune activation, and indices of fatigue. Twenty-two participants then crossed over to groups given gluten (16 g/d), whey (16 g/d), or control (no additional protein) diets for 3 days. Symptoms were evaluated by visual analogue scales.
In all participants, gastrointestinal symptoms consistently and significantly improved during reduced FODMAP intake, but significantly worsened to a similar degree when their diets included gluten or whey protein. Gluten-specific effects were observed in only 8% of participants. There were no diet-specific changes in any biomarker. During the 3-day rechallenge, participants' symptoms increased by similar levels among groups. Gluten-specific gastrointestinal effects were not reproduced. An order effect was observed.
In a placebo-controlled, cross-over rechallenge study, we found no evidence of specific or dose-dependent effects of gluten in patients with NCGS placed diets low in FODMAPs.
非乳糜泻麸质敏感(NCGS)患者没有乳糜泻,但当他们采用无麸质饮食时,其症状会得到改善。我们研究了在认为患有 NCGS 的患者减少可发酵、难吸收的短链碳水化合物(可发酵、寡糖、二糖、单糖和多元醇[FODMAP])饮食后,麸质的具体影响。
我们对 37 名(年龄 24-61 岁,6 名男性)患有 NCGS 和肠易激综合征(基于罗马 III 标准)但没有乳糜泻的患者进行了双盲交叉试验。参与者被随机分为两组,一组给予 2 周的低 FODMAP 饮食,然后分别给予高麸质(16 g 麸质/d)、低麸质(2 g 麸质/d 和 14 g 乳清蛋白/d)或对照(16 g 乳清蛋白/d)饮食 1 周,然后至少 2 周洗脱期。我们评估了血清和粪便中肠道炎症/损伤和免疫激活的标志物,以及疲劳指数。然后,22 名参与者交叉到给予麸质(16 g/d)、乳清(16 g/d)或对照(无额外蛋白质)饮食的组中,持续 3 天。通过视觉模拟量表评估症状。
在所有参与者中,在减少 FODMAP 摄入期间,胃肠道症状持续且明显改善,但当饮食中包含麸质或乳清蛋白时,症状同样明显恶化。只有 8%的参与者观察到麸质特异性效应。任何生物标志物均无饮食特异性变化。在 3 天的再挑战期间,各组参与者的症状增加水平相似。没有重现麸质特异性胃肠道效应。观察到顺序效应。
在一项安慰剂对照、交叉再挑战研究中,我们在接受低 FODMAP 饮食的 NCGS 患者中未发现麸质具有特异性或剂量依赖性影响的证据。